ContractCommon Stock Purchase Warrant • January 22nd, 2018 • Biocept Inc • Services-medical laboratories • New York
Contract Type FiledJanuary 22nd, 2018 Company Industry JurisdictionTHE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING DECEMBER 5, 2017 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) DAWSON JAMES SECURITIES, INC. OR A PLACEMENT AGENT OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS WARRANT WAS ISSUED TO THE PLACEMENT AGENT AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF DAWSON JAMES SECURITIES, INC. OR OF ANY SUCH PLACEMENT AGENT OR SELECTED DEALER.
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • January 22nd, 2018 • Biocept Inc • Services-medical laboratories
Contract Type FiledJanuary 22nd, 2018 Company IndustryTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”) is entered by and between Biocept, Inc., a Delaware corporation (the “Company”), and Michael W. Nall (“Executive”) and shall be effective as of November 1, 2017 (the “Amendment Effective Date”).